Disinfection of an Advanced Primary Effluent with Peracetic Acid and Ultraviolet Combined Treatment: A Continuous‐Flow Pilot Plant Study: Fid-Bau Portal

Disinfection of an Advanced Primary Effluent with Peracetic Acid and Ultraviolet Combined Treatment: A Continuous‐Flow Pilot Plant Study

González, Abelardo / Gehr, Ronald / Vaca, Mabel / López, Raymundo

Abstract

Disinfection of an advanced primary effluent using a continuous‐flow combined peracetic acid/ultraviolet (PAA/UV) radiation system was evaluated. The purpose was to determine whether the maximum microbial content, established under Mexican standards for treated wastewaters meant for reuse—less than 240 most probable number fecal coliforms (FC)/100 mL—could be feasibly accomplished using either disinfectant individually, or the combined PAA/UV system. This meant achieving reduction of up to 5 logs, considering initial concentrations of 6.4·10⁺⁶ to 5.8·10⁺⁷ colony forming units/100 mL. During the tests performed under these experiments, total coliforms (TC) were counted because FC, at the most, will be equal to TC. Peracetic acid disinfection achieved less than 1.5 logs TC reduction when the C_t·t product was less than 2.26 mg·minimum (min)/L; 3.8 logs for C_t·t 4.40 mg·min/L; and 5.9 logs for C_t·t 24.2 mg·min/L. In continuous‐flow UV irradiation tests, at a low‐operating flow (21 L/min; conditions which produced an average UV fluence of 13.0 mJ/cm²), the highest TC reduction was close to 2.5 logs. The only condition that produced a disinfection efficiency of approximately 5 logs, when both disinfection agents were used together, was the combined process dosing 30 mg PAA/L at a pilot plant flow of 21 L/min and contact time of 10 minutes to attain an average C_t·t product of 24.2 mg·min/L and an average UV fluence of 13 mJ/cm². There was no conclusive evidence of a synergistic effect when both disinfectants were employed in combination as compared to the individual effects achieved when used separately, but this does not take into account the nonlinearity (tailing‐off) of the dose‐response curve.